Please enable JavaScript to continue using this application.

Compare $CMPX vs $ORGO | Chartloom

Compare

$CMPX vs $ORGO

Compass Therapeutics Inc. · Organogenesis Holdings Inc

CMPX

Compass Therapeutics Inc.

ORGO

Organogenesis Holdings Inc

Compare $CMPX vs $ORGO

Comparing Compass Therapeutics Inc. and Organogenesis Holdings Inc

CMPXCompass Therapeutics Inc.

ORGOOrganogenesis Holdings Inc

CMPXCompass Therapeutics Inc.

Market cap

$179M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.51x

Rev growth (TTM)

—

YTD performance

-80.8%

52W performance

-74.5%

FCF yield

-31.5%

ORGOOrganogenesis Holdings Inc

Market cap

$166M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.74x

Rev growth (TTM)

6.5%

YTD performance

-72.2%

52W performance

-68.8%

FCF yield

12.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CMPX

ORGO

Detailed metrics comparison

CMPX

Compass Therapeutics Inc.

ORGO

Organogenesis Holdings Inc

Market Cap

CMPX$179M

ORGO$166M

Enterprise Value

CMPX$143M

ORGO$132M

Price

CMPX$0.99

ORGO$1.29

P/E Ratio

CMPXN/A

ORGON/A

P/S Ratio

CMPX0.00x

ORGO0.36x

EV/Sales

CMPX0.00x

ORGO0.29x

EV/EBITDA

CMPX0.00x

ORGO7.37x

P/B Ratio

CMPX0.93x

ORGO0.59x

P/FCF Ratio

CMPXN/A

ORGO7.96x

EV/FCF

CMPX-2.54x

ORGO6.31x

PEG Ratio

CMPXN/A

ORGON/A

Forward P/E (NTM)

CMPXN/A

ORGON/A

Forward P/S (NTM)

CMPX1.51x

ORGO0.74x

Revenue (TTM)

CMPX$0

ORGO$457M

Revenue Growth (YoY)

CMPXN/A

ORGO6.5%

Forward Rev Growth

CMPX397.5%

ORGO37.6%

Gross Margin (TTM)

CMPX0.0%

ORGO70.4%

Operating Margin (TTM)

CMPX0.0%

ORGO0.0%

EBITDA Margin (TTM)

CMPX0.0%

ORGO-2.0%

Net Margin (TTM)

CMPX0.0%

ORGO-23.1%

FCF Margin (TTM)

CMPXN/A

ORGO4.6%

Net Income (TTM)

CMPX$-30M

ORGO$-106M

FCF (TTM)

CMPX$-56M

ORGO$21M

EPS (TTM)

CMPX$0.00

ORGO-$0.82

ROE (TTM)

CMPX-2994.0%

ORGO-2260.0%

ROA (TTM)

CMPX-2635.0%

ORGO-1654.0%

ROIC (TTM)

CMPX-2994.0%

ORGO-2187.0%

Cash

CMPX$35M

ORGO$46M

Debt

CMPX$0

ORGO$12M

Net Cash/Debt

CMPX$35M

ORGO$34M

Current Ratio (TTM)

CMPX11.22x

ORGO3.52x

Quick Ratio (TTM)

CMPX11.15x

ORGO2.66x

Debt/Equity (TTM)

CMPX0.00x

ORGO0.04x

Debt/Assets (TTM)

CMPX0.0%

ORGO0.0%

Interest Coverage (TTM)

CMPXN/A

ORGON/A

Net Debt/EBITDA (TTM)

CMPX0.00x

ORGO0.00x

Beta

CMPX1.07

ORGO1.44

52W Performance

CMPX-74.5%

ORGO-68.8%

YTD Performance

CMPX-80.8%

ORGO-72.2%

% from 52W High

CMPX-85.6%

ORGO-81.8%

% from 52W Low

CMPX19.7%

ORGO3.2%

Asset Turnover (TTM)

CMPX0.00x

ORGO0.90x

FCF Yield (TTM)

CMPX-31.5%

ORGO12.6%

Earnings Yield (TTM)

CMPX-16.8%

ORGO-63.8%

Dividend Yield (TTM)

CMPXN/A

ORGON/A

Rule of 40

CMPX0.0

ORGO11.1

EV/GP/RG

CMPXN/A

ORGO0.01

Ticker research

View CMPX research View ORGO research

Metric	CMPX Compass Therapeutics Inc.	ORGO Organogenesis Holdings Inc
Market & Valuation
Market Cap	$179M	$166M
Enterprise Value	$143M	$132M
Price	$0.99	$1.29
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.36x
EV/Sales	0.00x	0.29x
EV/EBITDA	0.00x	7.37x
P/B Ratio	0.93x	0.59x
P/FCF Ratio	N/A	7.96x
EV/FCF	-2.54x	6.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.51x	0.74x
Revenue & Growth
Revenue (TTM)	$0	$457M
Revenue Growth (YoY)	N/A	6.5%
Forward Rev Growth	397.5%	37.6%
Profitability
Gross Margin (TTM)	0.0%	70.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2.0%
Net Margin (TTM)	0.0%	-23.1%
FCF Margin (TTM)	N/A	4.6%
Net Income (TTM)	$-30M	$-106M
FCF (TTM)	$-56M	$21M
EPS (TTM)	$0.00	-$0.82
ROE (TTM)	-2994.0%	-2260.0%
ROA (TTM)	-2635.0%	-1654.0%
ROIC (TTM)	-2994.0%	-2187.0%
Financial Health
Cash	$35M	$46M
Debt	$0	$12M
Net Cash/Debt	$35M	$34M
Current Ratio (TTM)	11.22x	3.52x
Quick Ratio (TTM)	11.15x	2.66x
Debt/Equity (TTM)	0.00x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.44
52W Performance	-74.5%	-68.8%
YTD Performance	-80.8%	-72.2%
% from 52W High	-85.6%	-81.8%
% from 52W Low	19.7%	3.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.90x
FCF Yield (TTM)	-31.5%	12.6%
Earnings Yield (TTM)	-16.8%	-63.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	11.1
EV/GP/RG	N/A	0.01
Ticker research	View CMPX research	View ORGO research

Valuation

P/S Ratio

CMPX

0.00x

ORGO

0.36x

EV/FCF

CMPX

-2.54x

ORGO

6.31x

Growth & revenue

Revenue Growth TTM

ORGO

6.5%

Forward Revenue Growth

CMPX

397.5%

ORGO

37.6%

Profitability & performance

Gross Margin

ORGO

70.4%

CMPX

0.0%

ROE

ORGO

-2260.0%

CMPX

-2994.0%

FCF Yield %

ORGO

12.6%

CMPX

-31.5%

52-Week Performance

ORGO

-68.8%

CMPX

-74.5%

Detailed metrics comparison

CMPX

Compass Therapeutics Inc.

ORGO

Organogenesis Holdings Inc

Market Cap

CMPX$179M

ORGO$166M

Enterprise Value

CMPX$143M

ORGO$132M

Price

CMPX$0.99

ORGO$1.29

P/E Ratio

CMPXN/A

ORGON/A

P/S Ratio

CMPX0.00x

ORGO0.36x

EV/Sales

CMPX0.00x

ORGO0.29x

EV/EBITDA

CMPX0.00x

ORGO7.37x

P/B Ratio

CMPX0.93x

ORGO0.59x

P/FCF Ratio

CMPXN/A

ORGO7.96x

EV/FCF

CMPX-2.54x

ORGO6.31x

PEG Ratio

CMPXN/A

ORGON/A

Forward P/E (NTM)

CMPXN/A

ORGON/A

Forward P/S (NTM)

CMPX1.51x

ORGO0.74x

Revenue (TTM)

CMPX$0

ORGO$457M

Revenue Growth (YoY)

CMPXN/A

ORGO6.5%

Forward Rev Growth

CMPX397.5%

ORGO37.6%

Gross Margin (TTM)

CMPX0.0%

ORGO70.4%

Operating Margin (TTM)

CMPX0.0%

ORGO0.0%

EBITDA Margin (TTM)

CMPX0.0%

ORGO-2.0%

Net Margin (TTM)

CMPX0.0%

ORGO-23.1%

FCF Margin (TTM)

CMPXN/A

ORGO4.6%

Net Income (TTM)

CMPX$-30M

ORGO$-106M

FCF (TTM)

CMPX$-56M

ORGO$21M

EPS (TTM)

CMPX$0.00

ORGO-$0.82

ROE (TTM)

CMPX-2994.0%

ORGO-2260.0%

ROA (TTM)

CMPX-2635.0%

ORGO-1654.0%

ROIC (TTM)

CMPX-2994.0%

ORGO-2187.0%

Cash

CMPX$35M

ORGO$46M

Debt

CMPX$0

ORGO$12M

Net Cash/Debt

CMPX$35M

ORGO$34M

Current Ratio (TTM)

CMPX11.22x

ORGO3.52x

Quick Ratio (TTM)

CMPX11.15x

ORGO2.66x

Debt/Equity (TTM)

CMPX0.00x

ORGO0.04x

Debt/Assets (TTM)

CMPX0.0%

ORGO0.0%

Interest Coverage (TTM)

CMPXN/A

ORGON/A

Net Debt/EBITDA (TTM)

CMPX0.00x

ORGO0.00x

Beta

CMPX1.07

ORGO1.44

52W Performance

CMPX-74.5%

ORGO-68.8%

YTD Performance

CMPX-80.8%

ORGO-72.2%

% from 52W High

CMPX-85.6%

ORGO-81.8%

% from 52W Low

CMPX19.7%

ORGO3.2%

Asset Turnover (TTM)

CMPX0.00x

ORGO0.90x

FCF Yield (TTM)

CMPX-31.5%

ORGO12.6%

Earnings Yield (TTM)

CMPX-16.8%

ORGO-63.8%

Dividend Yield (TTM)

CMPXN/A

ORGON/A

Rule of 40

CMPX0.0

ORGO11.1

EV/GP/RG

CMPXN/A

ORGO0.01

Ticker research

View CMPX research View ORGO research

Metric	CMPX Compass Therapeutics Inc.	ORGO Organogenesis Holdings Inc
Market & Valuation
Market Cap	$179M	$166M
Enterprise Value	$143M	$132M
Price	$0.99	$1.29
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.36x
EV/Sales	0.00x	0.29x
EV/EBITDA	0.00x	7.37x
P/B Ratio	0.93x	0.59x
P/FCF Ratio	N/A	7.96x
EV/FCF	-2.54x	6.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.51x	0.74x
Revenue & Growth
Revenue (TTM)	$0	$457M
Revenue Growth (YoY)	N/A	6.5%
Forward Rev Growth	397.5%	37.6%
Profitability
Gross Margin (TTM)	0.0%	70.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2.0%
Net Margin (TTM)	0.0%	-23.1%
FCF Margin (TTM)	N/A	4.6%
Net Income (TTM)	$-30M	$-106M
FCF (TTM)	$-56M	$21M
EPS (TTM)	$0.00	-$0.82
ROE (TTM)	-2994.0%	-2260.0%
ROA (TTM)	-2635.0%	-1654.0%
ROIC (TTM)	-2994.0%	-2187.0%
Financial Health
Cash	$35M	$46M
Debt	$0	$12M
Net Cash/Debt	$35M	$34M
Current Ratio (TTM)	11.22x	3.52x
Quick Ratio (TTM)	11.15x	2.66x
Debt/Equity (TTM)	0.00x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.44
52W Performance	-74.5%	-68.8%
YTD Performance	-80.8%	-72.2%
% from 52W High	-85.6%	-81.8%
% from 52W Low	19.7%	3.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.90x
FCF Yield (TTM)	-31.5%	12.6%
Earnings Yield (TTM)	-16.8%	-63.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	11.1
EV/GP/RG	N/A	0.01
Ticker research	View CMPX research	View ORGO research